EROSIVE AND ULCERATIVE LESIONS OF THE DIGESTIVE TRACT
Abstract
Erosive and ulcerative lesions of the digestive tract are one of the most pressing problems in the clinical practice of internal diseases due to their extremely widespread prevalence, the presence of severe complications, often fatal, diagnostic difficulties due to a large number of asymptomatic pathologies and difficulties in rational choice of therapy. Of particular note are the data that during the global pandemic, COVID-19 infection can quite often cause the development of erosive and ulcerative lesions of the gastrointestinal tract.
References
Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol. 2016;24(15):2283-9. DOI:10.1200/JCO.2005.04.5716
O’Reilly M, Mellotte G, Ryan B, O’Connor A. Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis. 2020;11:2040622320970354. DOI:10.1177/2040622320970354
Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology. 2015;128(5):1445-61. DOI:10.1053/j.gastro.2004.09.080
De Petris G, Caldero SG, Chen L, et al. Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II). Int J Surg Pathol. 2014;22(3):202-11. DOI:10.1177/1066896913502230
